[1]
2014. Epidermal growth factor polymorphism most prevalent in stage II cervical carcinoma. Universa Medicina. 33, 3 (Dec. 2014), 192–198. DOI:https://doi.org/10.18051/UnivMed.2014.v33.192-198.